New stock news: Jiangsu Hengrui Pharmaceuticals, Foritech, and Jinsheng New Energy have submitted their IPO application materials to the China Securities Regulatory Commission.

On January 17, the China Securities Regulatory Commission issued the "Table of Domestic Enterprises' Overseas Issuance of Securities and Listing Records (first-time public issuance and full circulation) (as of January 16, 2025)". This week (January 13 to January 17), Jiangsu Hengrui Pharmaceuticals, Fulatek, and Jinsheng New Energy's Hong Kong IPO application materials were accepted by the China Securities Regulatory Commission.